As undiagnosed and untreated periodontal disease is one of the fastest growing areas of litigation and complaints in dentistry1, acting early against gum disease has never been so important. The Dental Defence Union (DDU) recommends use of the Basic Periodontal Examination (BPE) to help reduce the risk of a claim for missing periodontal disease.
First produced by the British Society of Periodontology in 19862, the BPE is a simple screening tool to assess your patient’s periodontal status.
With over 30 years’ gum care expertise, Corsodyl® has recently launched two free materials to help in the identification and prevention of gum disease, using the BPE.
“Gum Health – A Practitioner’s Guide” is a handy booklet designed to refresh your knowledge of the BPE as well as the signs, symptoms and risk factors. Visit www.gsk-dentalprofessionals.co.uk to request your free copy.
Compatible with iPhones and iPads, the Corsodyl® “Guide to BPE & Gum Health” mobile app is designed to be a quick reference tool for the BPE. It features a description and clinical image of each BPE code and a summary of recommended treatment. To download the free app, visit the iTunes App Store and search “BPE app”.
- Dental Protection. Exercises in risk management. Periodontal monitoring. Available at http://www.dentalprotection.org/adx/aspx/adxGetMedia.aspx?DocID=1363. Accessed 12/05/14.
- British Society of Periodontology. Basic Periodontal Examination (BPE) guidance, 2011. Available at http://www.bsperio.org.uk/publications/downloads/39_143748_bpe2011.pdf. Accessed 12/05/14.
CORSODYL is a registered trade mark of the GSK group of companies.
Corsodyl Mint Mouthwash
Presentation: A colourless solution containing 0.2% w/v chlorhexidine digluconate. Indications: Plaque inhibition; gingivitis; maintenance of oral hygiene; post periodontal surgery or treatment; aphthous ulceration; oral candida. Dosage & Administration: Adults and children 12 years and over: Rinse with 10 ml for 1 minute twice daily or pre-surgery. Soak dentures for 15 minutes twice daily. Treatment length: gingivitis 1 month; ulcers, oral candida 48 hours after clinical resolution. Children under 12 on healthcare professional advice only. Contraindications: Hypersensitivity to chlorhexidine or any of the excipients. Precautions: Keep out of eyes and ears, do not swallow, separate use from conventional dentifrices (e.g. rinse mouth between applications). In case of soreness, swelling or irritation of the mouth cease use of product. Side effects: Superficial discolouration of tongue, teeth and tooth-coloured restorations, usually reversible; transient taste disturbances and burning sensation of tongue on initial use; oral desquamation; parotid swelling; irritative skin reactions; extremely rare, generalised allergic reactions, hypersensitivity and anaphylaxis. Overdose: Due to the alcohol content (7%) ingestion of large amounts by children requires medical attention. Legal category: GSL. Product Licence Number and RSP (excl. VAT): PL 00079/0312 300 ml £4.17, 600 ml £8.17. Licence Holder: GlaxoSmithKline Consumer Healthcare, Brentford, TW8 9GS, U.K. Date of preparation: July 2011.